Home
>
US Stocks
>
Nurix Therapeutics Inc
Nurix Therapeutics Inc
NRIX

Nurix Therapeutics Inc

$28.857.26%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
28.74
Today Low/High
28.21 / 29.02
52 Week Low/High
$21.39 / $52.38
Market Cap
$1.38B

Company Details

Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and other challenging diseases. Leveraging Nurix’s extensive expertise in E3 ligases together with its proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to identify and advance novel drug candidates targeting E3 ligases, a broad class of enzymes that can modulate proteins within the cell. Nurix’s drug discovery approach is to either harness or inhibit the natural function of E3 ligases within the ubiquitin proteasome system to selectively decrease or increase cellular protein levels. Nurix’s wholly owned pipeline includes targeted protein degraders of Bruton’s tyrosine kinase, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene B, an E3 ligase that regulates T cell activation. Nurix is headquartered in San Francisco, California.
Organisation
Nurix Therapeutics Inc
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Nurix Therapeutics Inc share price today

Can Indians buy Nurix Therapeutics Inc shares?

How can I buy Nurix Therapeutics Inc shares from India?

Can Fractional shares of Nurix Therapeutics Inc be purchased?

What are the documents required to start investing in Nurix Therapeutics Inc stocks?

We are a SEBI registered investement advisor